Preference for Emicizumab over Prior Factor Treatments: Results from the HAVEN 3 and HAVEN 4 Studies
暂无分享,去创建一个
J. Oldenburg | V. Jiménez‐Yuste | S. Chebon | J. Mahlangu | S. Pipe | M. Shima | M. Lehle | J. Windyga | P. Trask | M. Niggli | I. Paz‐Priel | A. Giermasz | A. Parnes | A. Campinha-Bacote